Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation

Lancet

Volumn 360, Issue 9350, 2002, Pages 2039-2045

  Moberg, L ^a   Johansson, H ^a   Lukinius, A ^a   Berne, C ^a   Foss, A ^b   Kallen R ^c   Ostraat O ^d   Salmela, K ^e   Tibell, A ^b   Tufveson, G ^a   Elgue, G ^a   Nilsson Ekdahl, K ^a,f   Korsgren, O ^a   Nilsson, Bo ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b Dept of Transplantation Surgery ^*  (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e UNIVERSITY OF HELSINKI   (Finland)

^f LINNAEUS UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7A; HEPARIN; INSULIN; MONOCLONAL ANTIBODY; THROMBOPLASTIN;

ARTICLE; BLOOD CLOTTING; BLOOD COMPATIBILITY; BLOOD GROUP ABO SYSTEM; CELL TRANSPLANTATION; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOCRINE CELL; EXOCRINE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IN VITRO STUDY; MOLECULAR BIOLOGY; PANCREAS ISLET CELL; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0037153731     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)12020-4     Document Type: Article

References (30)

1. Peppelenbosch M.P., Versteeg H.H. Cell biology of tissue factor, an unusual member of the cytokine receptor family. Trends Cardiovasc Med. 11:2001;335-339.
2. Drake T.A., Morrissey J.H., Edgington T.S. Selective cellular expression of tissue factor in human tissues: implications for disorders of hemostasis and thrombosis. Am J Pathol. 134:1989;1087-1097.
3. Luther T., Flossel C., Mackman N., et al. Tissue factor expression during human and mouse development. Am J Pathol. 149:1996;101-113.
4. Morrissey J.H. Tissue factor: an enzyme cofactor and a true receptor. Thromb Haemost. 86:2001;66-74.
5. Shapiro A.M., Lakey J.R., Ryan E.A., et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 343:2000;230-238.
6. Ryan E.A., Lakey J.R., Rajotte R.V., et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes. 50:2001;710-719.
7. Froberg M.K., Leone J.P., Jessurun J., Sutherland D.E. Fatal disseminated intravascular coagulation after autologous islet transplantation. Hum Pathol. 28:1997;1295-1298.
8. Shapiro A.M., Lakey J.R., Rajotte R.V., et al. Portal vein thrombosis after transplantation of partially purified pancreatic islets in a combined human liver/islet allograft. Transplantation. 59:1995;1060-1063.
9. Bennet W., Sundberg B., Groth C.G., et al. Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes. 48:1999;1907-1914.
10. Ozmen L., Ekdahl K.N., Elgue G., Larsson R., Korsgren O., Nilsson B. Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: possible application of the thrombin inhibitor melagatran in clinical islet transplantation. Diabetes. 51:2002;1779-1784.
11. Brandhorst H., Brandhorst D., Brendel M.D., Hering B.J., Bretzel R.G. Assessment of intracellular insulin content during all steps of human islet isolation procedure. Cell Transplant. 7:1998;489-495.
12. Ricordi C., Lacy P.E., Finke E.H., Olack B.J., Scharp D.W. Automated method for isolation of human pancreatic islets. Diabetes. 37:1988;413-420.
13. Lakey J.R., Warnock G.L., Shapiro A.M., et al. Intraductal collagenase delivery into the human pancreas using syringe loading or controlled perfusion. Cell Transplant. 8:1999;285-292.
14. Wildgoose P., Berkner K.L., Kisiel W. Synthesis, purification, and characterization of an Arg152 - - Glu site-directed mutant of recombinant human blood clotting factor VII. Biochemistry. 29:1990;3413-3420.
15. Ekdahl K.N., Ronnblom L., Sturfelt G., Nilsson B. Increased phosphate content in complement component C3, fibrinogen, vitronectin, and other plasma proteins in systemic lupus erythematosus: covariation with platelet activation and possible association with thrombosis. Arthritis Rheum. 40:1997;2178-2186.
16. Lukinius A., Ericsson J.L., Grimelius L., Korsgren O. Ultrastructural studies of the ontogeny of fetal human and porcine endocrine pancreas, with special reference to colocalization of the four major islet hormones. Dev Biol. 153:1992;376-385.
17. Lukinius A., Korsgren O. The transplanted fetal endocrine pancreas undergoes an inherent sequential differentiation similar to that in the native pancreas: an ultrastructural study in the pig-to-mouse model. Diabetes. 50:2001;962-971.
18. Gong J., Larsson R., Ekdahl K.N., Mollnes T.E., Nilsson U., Nilsson B. Tubing loops as a model for cardiopulmonary bypass circuits: both the biomaterial and the blood-gas phase interfaces induce complement activation in an in vitro model. J Clin Immunol. 16:1996;222-229.
19. Larsson R., Elgue G., Larsson A., Ekdahl K.N., Nilsson U.R., Nilsson B. Inhibition of complement activation by soluble recombinant CR1 under conditions resembling those in a cardiopulmonary circuit: reduced upregulation of CD11b and complete abrogation of binding of PMNs to the biomaterial surface. Immunopharmacology. 38:1997;119-127.
20. Parker R.C., Castor L.N., McCulloch E.A. Altered cell strains in continuous culture: a general survey. N Y Acad Sci. 5:1957;303-313.
21. Sanchez J., Elgue G., Riesenfeld J., Olsson P. Studies of adsorption, activation, and inhibition of factor XII on immobilized heparin. Thromb Res. 89:1998;41-50.
22. Mollnes T.E., Lea T., Harboe M., Tschopp J. Monoclonal antibodies recognizing a neoantigen of poly(C9) detect the human terminal complement complex in tissue and plasma. Scand J Immunol. 22:1985;183-195.
23. Nilsson Ekdahl K., Nilsson B., Pekna M., Nilsson U.R. Generation of iC3 at the interface between blood and gas. Scand J Immunol. 35:1992;85-91.
24. Gough N.M. Rapid and quantitative preparation of cytoplasmic RNA from small numbers of cells. Anal Biochem. 173:1988;93-95.
25. Potgens A.J., Lubsen N.H., van Altena G., Schoenmakers J.G., Ruiter D.J., de Waal R.M. Measurement of tissue factor messenger RNA levels in human endothelial cells by a quantitative RT-PCR assay. Thromb Haemost. 71:1994;208-213.
26. van Suylichem P.T., van Deijnen J.E., Wolters G.H., van Schilfgaarde R. Amount and distribution of collagen in pancreatic tissue of different species in the perspective of islet isolation procedures. Cell Transplant. 4:1995;609-614.
27. Colman R.W., Scott C.F. When and where is factor XI activated by thrombin? Blood. 87:1996;2089.
28. Mavrommatis A.C., Theodoridis T., Orfanidou A., Roussos C., Christopoulou-Kokkinou V., Zakynthinos S. Coagulation system and platelets are fully activated in uncomplicated sepsis. Crit Care Med. 28:2000;451-457.
29. Pazzagli M., Mazzantini D., Cella G., Rampin E., Palla A. Value of thrombin-antithrombin III complexes in major orthopedic surgery: relation to the onset of venous thromboembolism. Clin Appl Thromb Hemost. 5:1999;228-231.
30. Zhang Y., Deng Y., Luther T., et al. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest. 94:1994;1320-1327.